Quarterly Results

NASDAQ
SPPI
$8.10
+0.00
DAY HI:
$8.15
DAY LOW:
$7.80
VOLUME:
0
4:00 PM EST 07/18/19

Quarterly Results

2018
Third Quarter
Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results
Spectrum Pharmaceuticals 3Q 2018 Earnings Call (Nov 8, 2018 @ 1:30 PM PST)
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update
Spectrum Pharmaceuticals 2Q 2018 Earnings Call (Aug 9, 2018 1:30 PM PDT)
Form 10-Q
First Quarter
Spectrum Pharmaceuticals 1Q 2018 Earnings Call (May 3, 2018 1:30 PM PDT)
Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update
Form 10-Q
2017
Fourth Quarter
Spectrum Pharmaceuticals 4Q 2017 Earnings Call (Mar 6, 2018 @ 1:30 PM PST)
Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update
Form 10-K
Third Quarter
Spectrum Pharmaceuticals 3Q 2017 Earnings Call (Nov 2, 2017 @ 4:30 PM EDT)
Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals 2Q 2017 Earnings Call (Aug 3, 2017 @ 4:30 PM EDT)
Spectrum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Pipeline Update
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update
Spectrum Pharmaceuticals 1Q 2017 Earnings Call (May 2, 2017 @ 4:30 PM EDT)
Form 10-Q
2016
Fourth Quarter
Spectrum Pharmaceuticals 4Q 2016 Earnings Call (Mar 8, 2017 @ 4:30 PM EST)
Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update
Form 10-Q
Spectrum Pharmaceuticals 2Q 2016 Earnings Call (Aug 9, 2016 @ 4:30 PM EDT)
First Quarter
Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
Form 10-Q
Spectrum Pharmaceuticals 1Q 2016 Earnings Call (May 5, 2016 @ 4:30 PM EDT)
2015
Fourth Quarter
Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update
Form 10-K
Fourth Quarter 2015 Financial Results Conference Call (Mar 9, 2016 @ 1:30 PM PST)
Third Quarter
Spectrum Pharmaceuticals Reports Third Quarter 2015 Financial Results and Pipeline Update
Form 10-Q
Third Quarter 2015 Financial Results Conference Call (Nov 4, 2015 @ 1:30 PM PST)
Second Quarter
Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update
Form 10-Q
Second Quarter 2015 Financial Results Conference Call (Aug 6, 2015 @ 1:30 PM PDT)
First Quarter
Spectrum Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results
Form 10-Q
2014
Fourth Quarter
Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014
Form 10-Q
2013
Fourth Quarter
Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Reports Financial Results for Third Quarter 2013
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Reports Financial Results for Second Quarter 2013
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2013
Form 10-Q
2012
Fourth Quarter
Spectrum Pharmaceuticals Reports Record Revenues, Profits, and Cash Generated from Operations for the Twelve-Month Period Ended December 31, 2012
Form 10-K
Third Quarter
INSERTING and REPLACING Spectrum Pharmaceuticals Reports Strong Revenues and Profits for Third Quarter; Revenues of $69 million up 35% over last year and GAAP Diluted EPS of $0.33 and Non-GAAP Diluted EPS of $0.42
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Reports Record Revenues and Strong Profits for Second Quarter; Revenues of $68.7 Million up 51.5% over Last Year and Strong non-GAAP EPS of $0.37, up 48% over Last Year
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Reports Record Revenues and Profits for First Quarter of 2012
Form 10-Q
2011
Fourth Quarter
Spectrum Pharmaceuticals Reports Record Revenues, Profits, and Cash Generated from Operations for the Twelve-Month Period Ended December 31, 2011
Form 10-K
Third Quarter
Spectrum Pharmaceuticals, Inc. Reports Strongest Financial Position in Company History: Record Revenues, Profits, and Cash Generated from Operations for the Three- and Nine-Month Periods Ended September 30, 2011
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Generates Cash from Operations, Reports Third Consecutive Profitable Quarter, and Record Revenue for the Three- and Six-Month Periods Ended June 30, 2011; Strongest Financial Position in Company History
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Reports Record Profit and Record Revenue for First Quarter 2011, a Four-Fold Revenue Increase over First Quarter 2010
Form 10-Q
2010
Fourth Quarter
Spectrum Pharmaceuticals Reports Profitable Fourth Quarter and Record Revenue Growth for 2010
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Announces Third Quarter 2010 Financial and Operating Results
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Announces Second Quarter 2010 Corporate Update
First Quarter
Spectrum Pharmaceuticals Announces First Quarter 2010 Corporate Update
Form 10-Q
2009
Fourth Quarter
Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2009 Corporate Update
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; ZEVALIN® Sales up 80% over Third Quarter 2008
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Announces Second Quarter 2009 Corporate Update
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Announces First Quarter 2009 Corporate Update and Pipeline Review
Form 10-Q
2008
Fourth Quarter
Spectrum Pharmaceuticals Announces Fiscal Year 2008 Corporate Update and Pipeline Review
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Announces Third Quarter Corporate Update and Pipeline Review
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Announces Second Quarter 2008 Corporate Update and Pipeline Review Conference Call
Form 10-Q
First Quarter
Spectrum Pharmaceuticals Announces First Quarter 2008 Financial Results and Pipeline Update
Form 10-Q
2007
Fourth Quarter
Spectrum Pharmaceuticals Announces 2007 Financial Results and Pipeline Update
Form 10-K
Third Quarter
Spectrum Pharmaceuticals Announces Third Quarter 2007 Financial Results and Pipeline Update
Form 10-Q
Second Quarter
Spectrum Pharmaceuticals Announces Second Quarter 2007 Financial Results and Pipeline Update
Form 10-Q
First Quarter
Form 10-Q
2006
Fourth Quarter
Form 10-K/A
Third Quarter
Form 10-Q
Second Quarter
Form 10-Q
First Quarter
Form 10-Q